Profilin1 E117G is a moderate risk factor for amyotrophic lateral sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 5, 2014, Pages 506-508

  Fratta, Pietro ^a   Charnock, James ^a   Collins, Toby ^a   Devoy, Anny ^a   Howard, Robin ^a,b   Malaspina, Andrea ^c   Orrell, Richard ^a   Sidle, Katie ^a,b   Clarke, Jan ^a,b   Shoai, Maryam ^a   Lu, Ching Hua ^a,c   Hardy, John ^a   Plagnol, Vincent ^d   Fisher, Elizabeth M C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALLELE; AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATOR GENE; PRIORITY JOURNAL; PROFILIN 1 GENE; RISK FACTOR; UNITED KINGDOM;

ALS; NEUROGENETICS;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; FRONTOTEMPORAL DEMENTIA; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MUTATION; PROFILINS; RISK FACTORS;

EID: 84898604449     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-306761     Document Type: Article

References (13)

1. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995;118(Pt 3):707-19.
2. Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol 2011;7:603-15.
3. Lillo P, Hodges JR. Frontotemporal dementia and motor neurone disease: overlapping clinic-pathological disorders. J Clin Neurosci 2009;16:1131-5.
4. Wu C-H, Fallini C, Ticozzi N, et al. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature 2012;488:499-503.
5. Daoud H, Dobrzeniecka S, Camu W, et al. Mutation analysis of PFN1 in familial amyotrophic lateral sclerosis patients. Neurobiol Aging 2013;34:1311.e1-1311.e2.
6. Dillen L, Van Langenhove T, Engelborghs S, et al. Explorative genetic study of UBQLN2 and PFN1 in an extended Flanders-Belgian cohort of frontotemporal lobar degeneration patients. Neurobiol Aging 2013;34:1711.e1-5.
7. Ingre C, Landers JE, Rizik N, et al. A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts. Neurobiol Aging 2013;34:1708.e1- 1708.e6.
8. Lattante S, Le Ber I, Camuzat A, et al. Mutations in the PFN1 gene are not a common cause in patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration in France. Neurobiol Aging 2013;34:1709.e1-1709.e2.
9. Tiloca C, Ticozzi N, Pensato V, et al. Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia. Neurobiology of Aging 2013;34:1517.e9-1517.e10.
10. Van Blitterswijk M, Baker MC, Bieniek KF, et al. Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia. Amyotroph Lateral Scler Frontotemporal Degener 2013;14:463-9.
11. Yang S, Fifita JA, Williams KL, et al. Mutation analysis and immunopathological studies of PFN1 in familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging 2013;34:2235.e7-2235.e10.
12. van Blitterswijk M, van Es MA, Hennekam EAM, et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum Mol Genet 2012;21:3776-84.
13. Coppola G, Chinnathambi S, Lee JJ, et al. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet 2012;21:3500-12.